ROCURONIUM BROMIDE
- Product NDC
- 51662-1641
- 11-digit product format
- 516621641
- Labeler code
- 51662
- Product ID
- 51662-1641_15897860-d6aa-07e5-e063-6394a90aec75
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ROCURONIUM BROMIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA205656
- Marketing category
- ANDA
- Marketing start
- 2023-07-17
- Substance
- ROCURONIUM BROMIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ROCURONIUM BROMIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ROCURONIUM BROMIDE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | I65MW4OFHZ |
DailyMed Product Concepts#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51662-1641-1 | 51662164101 | 10 mL in 1 VIAL, MULTI-DOSE (51662-1641-1) | 10 ml | 2023-07-17 | No | No | Current |